• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
NASH and cryptogenic cirrhosis: a histological analysis.非酒精性脂肪性肝炎和隐源性肝硬化:组织学分析。
Ann Hepatol. 2009 Oct-Dec;8(4):346-52.
2
Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.隐源性肝硬化:潜在疾病的临床特征及危险因素
Hepatology. 1999 Mar;29(3):664-9. doi: 10.1002/hep.510290347.
3
Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.非酒精性脂肪性肝炎所致肝硬化与慢性丙型肝炎所致肝硬化的临床特征及转归比较
J Gastroenterol Hepatol. 2009 Feb;24(2):248-54. doi: 10.1111/j.1440-1746.2008.05640.x. Epub 2008 Nov 20.
4
Risk factors for nonalcoholic steatohepatitis in cryptogenic cirrhosis.隐源性肝硬化中非酒精性脂肪性肝炎的危险因素。
Arq Gastroenterol. 2012 Dec;49(4):245-9. doi: 10.1590/s0004-28032012000400003.
5
Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?非酒精性脂肪性肝炎相关肝细胞癌在肝硬化和非肝硬化患者中是否存在?
Braz J Med Biol Res. 2009 Oct;42(10):958-62. doi: 10.1590/s0100-879x2009005000019. Epub 2009 Sep 4.
6
Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds.家族性非酒精性脂肪性肝炎和隐源性肝硬化
Am J Med. 2000 Jan;108(1):9-13. doi: 10.1016/s0002-9343(99)00315-0.
7
Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.隐源性肝硬化与移植后非酒精性脂肪性肝病
Liver Transpl. 2001 Sep;7(9):797-801. doi: 10.1053/jlts.2001.24644.
8
Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis.非酒精性脂肪性肝炎相关非肝硬化肝细胞癌。
J Gastroenterol. 2009;44(12):1190-4. doi: 10.1007/s00535-009-0112-0.
9
The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options.隐匿性肝硬化的难题:无治疗选择的不良结局。
J Hepatol. 2018 Dec;69(6):1365-1370. doi: 10.1016/j.jhep.2018.08.013. Epub 2018 Aug 23.
10
Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.肝移植治疗隐源性肝硬化或非酒精性脂肪性肝病后的非酒精性脂肪性肝病。
Liver Transpl. 2010 Apr;16(4):431-9. doi: 10.1002/lt.22004.

引用本文的文献

1
Abnormalities of intracellular organelles in metabolic dysfunction-associated steatotic disease.代谢功能障碍相关脂肪性肝病中细胞内细胞器的异常
J Gastroenterol. 2025 May 9. doi: 10.1007/s00535-025-02257-5.
2
Antiplatelet Prophylaxis Reduces the Risk of Early Hepatic Artery Thrombosis Following Liver Transplantation in High-Risk Patients.抗血小板预防可降低高危患者肝移植后早期肝动脉血栓形成的风险。
Transpl Int. 2024 Dec 18;37:13440. doi: 10.3389/ti.2024.13440. eCollection 2024.
3
NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review.非酒精性脂肪性肝病(MASLD)/非酒精性脂肪性肝炎(MASH):是否有必要进行标记?全面的叙述性综述。
Int J Mol Sci. 2024 Aug 2;25(15):8462. doi: 10.3390/ijms25158462.
4
Development of fatty liver disease model using high cholesterol and low choline diet in white leghorn chickens.利用高胆固醇和低胆碱饮食在白来航鸡中开发脂肪肝疾病模型。
Vet Res Commun. 2024 Aug;48(4):2489-2497. doi: 10.1007/s11259-024-10420-1. Epub 2024 Jun 11.
5
Primary Care Utilization, Preventative Screening, and Control of Metabolic Syndrome in Metabolic Dysfunction-Associated Steatohepatitis Liver Transplant Recipients.代谢功能障碍相关脂肪性肝炎肝移植受者的初级保健利用、预防性筛查和代谢综合征控制。
J Prim Care Community Health. 2024 Jan-Dec;15:21501319241247974. doi: 10.1177/21501319241247974.
6
Development of Clinical Algorithm Utilizing Vibration-Controlled Transient Elastography to Detect Advanced Hepatic Fibrosis in Liver Transplant Recipients.利用振动控制瞬时弹性成像开发临床算法以检测肝移植受者的晚期肝纤维化。
Dig Dis Sci. 2024 May;69(5):1844-1851. doi: 10.1007/s10620-024-08366-0. Epub 2024 Mar 18.
7
The therapeutic mechanisms and beneficial effects of ursodeoxycholic acid in the treatment of nonalcoholic fatty liver disease: a systematic review.熊去氧胆酸治疗非酒精性脂肪性肝病的治疗机制及有益作用:一项系统评价
Med Pharm Rep. 2024 Jan;97(1):12-25. doi: 10.15386/mpr-2629. Epub 2024 Jan 29.
8
Updates in Characteristics and Survival Rates of Hepatocellular Carcinoma in a Nationwide Cohort of Real-World US Patients, 2003-2021.2003 - 2021年美国全国真实世界患者队列中肝细胞癌的特征及生存率更新
J Hepatocell Carcinoma. 2023 Dec 2;10:2147-2158. doi: 10.2147/JHC.S420603. eCollection 2023.
9
Histological findings and NAFLD/NASH Status in liver biopsies of patients subjected to bariatric surgery.行减重手术患者的肝活检组织学发现和非酒精性脂肪性肝病/非酒精性脂肪性肝炎状况。
Arch Endocrinol Metab. 2023 Nov 10;68:e220138. doi: 10.20945/2359-4292-2022-0138.
10
Liver Transplant Outcomes in Young Adults with Cirrhosis Related to Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病相关肝硬化的年轻成人肝移植结局。
Transplant Proc. 2023 Nov;55(9):2134-2142. doi: 10.1016/j.transproceed.2023.08.020. Epub 2023 Sep 24.

本文引用的文献

1
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis.非酒精性脂肪性肝炎纤维化进展危险因素的系统评价
J Hepatol. 2009 Aug;51(2):371-9. doi: 10.1016/j.jhep.2009.03.019. Epub 2009 May 3.
2
Thiazolidinediones for the treatment in NASH: sustained benefit after drug discontinuation?噻唑烷二酮类药物用于非酒精性脂肪性肝炎的治疗:停药后是否仍有持续疗效?
J Clin Gastroenterol. 2009 Jul;43(6):565-8. doi: 10.1097/MCG.0b013e31818f4fc2.
3
Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network.非酒精性脂肪性肝病(NAFLD)中的门静脉慢性炎症:非酒精性脂肪性肝炎临床研究网络的晚期NAFLD组织学标志物——临床病理相关性
Hepatology. 2009 Mar;49(3):809-20. doi: 10.1002/hep.22724.
4
Pathology of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的病理学
Am J Clin Pathol. 2007 Nov;128(5):837-47. doi: 10.1309/RTPM1PY6YGBL2G2R.
5
Long-term follow-up of patients with NAFLD and elevated liver enzymes.非酒精性脂肪性肝病(NAFLD)及肝酶升高患者的长期随访
Hepatology. 2006 Oct;44(4):865-73. doi: 10.1002/hep.21327.
6
Cryptogenic cirrhosis and NAFLD: are they related?隐源性肝硬化与非酒精性脂肪性肝病:它们有关联吗?
Am J Gastroenterol. 2006 Mar;101(3):664-8. doi: 10.1111/j.1572-0241.2006.00478.x. Epub 2006 Feb 8.
7
The natural history of nonalcoholic fatty liver disease: a population-based cohort study.非酒精性脂肪性肝病的自然史:一项基于人群的队列研究。
Gastroenterology. 2005 Jul;129(1):113-21. doi: 10.1053/j.gastro.2005.04.014.
8
Design and validation of a histological scoring system for nonalcoholic fatty liver disease.非酒精性脂肪性肝病组织学评分系统的设计与验证
Hepatology. 2005 Jun;41(6):1313-21. doi: 10.1002/hep.20701.
9
Histological progression of non-alcoholic fatty liver disease in Chinese patients.
Aliment Pharmacol Ther. 2005 Feb 15;21(4):407-13. doi: 10.1111/j.1365-2036.2005.02334.x.
10
Ethnic differences in the prevalence of cryptogenic cirrhosis.
Am J Gastroenterol. 2004 Feb;99(2):292-8. doi: 10.1111/j.1572-0241.2004.04059.x.

非酒精性脂肪性肝炎和隐源性肝硬化:组织学分析。

NASH and cryptogenic cirrhosis: a histological analysis.

机构信息

Division of Gastroenterology and Hepatology, Digestive Health Center, University of Virginia, Charlottesville, Virginia 22908, USA.

出版信息

Ann Hepatol. 2009 Oct-Dec;8(4):346-52.

PMID:20009134
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8381243/
Abstract

INTRODUCTION

Epidemiological studies indicate that nonalcoholic steatohepatitis (NASH) is a common cause of cirrhosis described as 'cryptogenic'. To address this from a histological perspective and to examine the significance of residual histological findings as an indication of prior NASH, we looked back at biopsies in patients who presented with cirrhosis without sufficient histological features to diagnose NASH but who had prior histologically confirmed non-cirrhotic NASH.

METHODS

Seven patients were identified with biopsy pairs showing non-specific (cryptogenic) cirrhosis in the latest specimen and a prior biopsy showing non-cirrhotic NASH. Using an expanded NASH-CRN system scored blindly by light microscopy, we compared the early and late biopsies to each other and to a cohort of 13 patients with cirrhosis due to hepatitis C without co-existing metabolic syndrome.

RESULTS

Macrosteatosis, although uniformly present in the non-cirrhotic NASH specimens, declined in the late stage cirrhotic NASH specimens and was not useful in the distinction of late cirrhotic NASH from cirrhotic viral hepatitis. However, the presence of ballooned cells, Mallory-Denk bodies, and megamitochondria and the absence of apoptotic bodies were significantly different in late stage cirrhotic NASH compared to cirrhosis due to hepatitis C.

CONCLUSIONS

Histologically advanced NASH presenting as non-specific or cryptogenic cirrhosis has residual changes which are consistent with prior steatohepatitis but which differ from cirrhosis due to hepatitis C. These results provide histological support for the more established epidemiological associations of NASH with cryptogenic cirrhosis and for criteria used in several proposed classifications of cryptogenic cirrhosis.

摘要

简介

流行病学研究表明,非酒精性脂肪性肝炎(NASH)是一种常见的“隐匿性”肝硬化病因。为了从组织学角度解决这个问题,并研究残留组织学发现作为先前 NASH 指示的意义,我们回顾了一些患者的活检,这些患者因肝硬化就诊,但组织学特征不足以诊断 NASH,但先前的组织学检查已证实存在非肝硬化性 NASH。

方法

确定了 7 名患者,他们的最新活检标本显示为非特异性(隐匿性)肝硬化,而先前的活检标本显示为非肝硬化性 NASH。我们使用扩展的 NASH-CRN 系统,通过光学显微镜进行盲法评分,将早期和晚期活检相互比较,并与 13 名因丙型肝炎导致的肝硬化而无并存代谢综合征的患者进行比较。

结果

尽管非肝硬化性 NASH 标本中普遍存在大泡性脂肪变性,但在晚期肝硬化性 NASH 标本中减少,并且在晚期肝硬化性 NASH 与丙型肝炎导致的肝硬化的鉴别中没有用处。然而,晚期肝硬化性 NASH 与丙型肝炎导致的肝硬化相比,气球样细胞、Mallory-Denk 体、巨线粒体的存在和凋亡小体的缺失存在显著差异。

结论

表现为非特异性或隐匿性肝硬化的组织学晚期 NASH 仍有残留变化,这些变化与先前的肝炎一致,但与丙型肝炎导致的肝硬化不同。这些结果为 NASH 与隐匿性肝硬化的更广泛的流行病学关联以及几个隐匿性肝硬化分类标准中使用的标准提供了组织学支持。